Skip to Content
NCI Patient-Derived Models Repository (PDMR) - An NCI Precision Oncology Initiative Resource
Contact PDMR
Show menu
Search this site
Last Updated: 09/01/21

Citing NCI Patient-Derived Models and Associated Data

  • To cite the PDMR as a reference, use a format similar to that shown below:

    The NCI Patient-Derived Models Repository (PDMR), NCI-Frederick, Frederick National Laboratory for Cancer Research, Frederick, MD. URL — https://pdmr.cancer.gov/.

  • To cite models in the Methods section, the full distribution lot name should be used in the publication (e.g., 123456-001-R, 123456-001-R-J1-PDC), not an abbreviated form. In addition, the Contributor name, the lot# received, and the passage of material used for analysis should be cited. The name of the Contributor for a model is noted at the patient level in the PDMR database. Use a format similar to that shown below:

    • To cite models developed by the PDMR:

      • Example: The PDX models 123456-001-R [Lot# AA1111] and 789123-001-R [Lot# BB2222] used in this study were developed by NCI PDMR.

    • To cite models developed by Contributing Institutions:

      • Example: The PDX models LG0123-001-R [Lot# AA111] and K12345-001-R [Lot# BB222] used in this study were developed by The Jackson Laboratory (Bar Harbor, ME) and are available from the NCI Patient Derived Models Repository (NCI PDMR; Frederick, MD; https://pdmr.cancer.gov).
      • Example: The PDX model K12345-001-R [Lot# AA1111] used in this study was developed by MD Anderson Cancer Center (Houston, TX) and is available from the NCI Patient Derived Models Repository (NCI PDMR; Frederick, MD; https://pdmr.cancer.gov).
  • Any modifications to the distributed model should be identified (e.g., transfection, CRISPR, etc.).
  • Sequence files downloaded for use in analysis should be referenced including the version# listed in the file name as different pipeline versions may result in different interpretations of the data (e.g., v1.2, v1.3, v2.0.1.51.0).